Liu, T., Woyach, J. A., Zhong, Y., Lozanski, A., Lozanski, G., Dong, S., . . . Johnson, A. J. (2015). Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation. Blood.
Chicago-tyylinen lähdeviittausLiu, Ta-Ming, et al. "Hypermorphic Mutation of Phospholipase C, γ2 Acquired in Ibrutinib-resistant CLL Confers BTK Independency Upon B-cell Receptor Activation." Blood 2015.
MLA-viiteLiu, Ta-Ming, et al. "Hypermorphic Mutation of Phospholipase C, γ2 Acquired in Ibrutinib-resistant CLL Confers BTK Independency Upon B-cell Receptor Activation." Blood 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.